about
A Blueprint for HIV Vaccine DiscoveryAntibody responses to envelope glycoproteins in HIV-1 infectionHIV-1 neutralizing antibodies: understanding nature's pathwaysDevelopmental pathway for potent V1V2-directed HIV-neutralizing antibodiesDeconstructing the Antiviral Neutralizing-Antibody Response: Implications for Vaccine Development and ImmunityBroadly Neutralizing Antibody PGT121 Allosterically Modulates CD4 Binding via Recognition of the HIV-1 gp120 V3 Base and Multiple Surrounding GlycansNeutralizing antibodies to HIV-1 envelope protect more effectively in vivo than those to the CD4 receptorHIV-1 and hijacking of the host immune system: the current scenario.Immune responses during spontaneous control of HIV and AIDS: what is the hope for a cure?A comparison of elasticities of viral levels to specific immune response mechanisms in human immunodeficiency virus infection.Broadly Neutralizing Antibodies as Treatment: Effects on Virus and Immune SystemCharacterization of VRC01, a potent and broadly neutralizing anti-HIV mAb, produced in transiently and stably transformed tobacco.The presence of glutamine at position 315 but not epitope masking predominantly hinders HIV subtype C neutralization by the anti-V3 antibody B4e8.Phages and HIV-1: from display to interplay.Superinfection by discordant subtypes of HIV-1 does not enhance the neutralizing antibody response against autologous virus.Deep Panning: steps towards probing the IgOme.The stem of vesicular stomatitis virus G can be replaced with the HIV-1 Env membrane-proximal external region without loss of G function or membrane-proximal external region antigenic properties.Glycosylation of the core of the HIV-1 envelope subunit protein gp120 is not required for native trimer formation or viral infectivity.Transmitted virus fitness and host T cell responses collectively define divergent infection outcomes in two HIV-1 recipients.The role of cell-associated virus in mother-to-child HIV transmission.An investigation of the breadth of neutralizing antibody response in cats naturally infected with feline immunodeficiency virusA High Throughput Protein Microarray Approach to Classify HIV Monoclonal Antibodies and Variant Antigens.Sustained Delivery of a Broadly Neutralizing Antibody in Nonhuman Primates Confers Long-Term Protection against Simian/Human Immunodeficiency Virus InfectionThe HIV-1 epidemic: low- to middle-income countries.The HIV Epidemic: High-Income Countries.Cocrystal Structures of Antibody N60-i3 and Antibody JR4 in Complex with gp120 Define More Cluster A Epitopes Involved in Effective Antibody-Dependent Effector Function against HIV-1The challenges of modelling antibody repertoire dynamics in HIV infection.Reactivity of routine HIV antibody tests in children who initiated antiretroviral therapy in early infancy as part of the Children with HIV Early Antiretroviral Therapy (CHER) trial: a retrospective analysis.Targeted Isolation of Antibodies Directed against Major Sites of SIV Env Vulnerability.Lessons in nonhuman primate models for AIDS vaccine research: from minefields to milestones.Design and characterization of a peptide mimotope of the HIV-1 gp120 bridging sheetCompetitive exclusion by autologous antibodies can prevent broad HIV-1 antibodies from arising.Association of HIV-1 Envelope-Specific Breast Milk IgA Responses with Reduced Risk of Postnatal Mother-to-Child Transmission of HIV-1Elite Control, Gut CD4 T Cell Sparing, and Enhanced Mucosal T Cell Responses in Macaca nemestrina Infected by a Simian Immunodeficiency Virus Lacking a gp41 Trafficking Motif.Design and structure of two HIV-1 clade C SOSIP.664 trimers that increase the arsenal of native-like Env immunogens.Broad neutralization by a combination of antibodies recognizing the CD4 binding site and a new conformational epitope on the HIV-1 envelope protein.Experimental Estimation of the Effects of All Amino-Acid Mutations to HIV's Envelope Protein on Viral Replication in Cell CultureHIV transmission biology: translation for HIV prevention.A mouse model for HIV-1 entryNew Member of the V1V2-Directed CAP256-VRC26 Lineage That Shows Increased Breadth and Exceptional Potency
P2860
Q26829865-FC8E6D94-7CEB-4036-B7B1-522879E6C6D5Q26991572-B96AFB3E-08DF-4366-895A-E461217AF7FEQ27000480-04635E66-A62F-457C-91F6-5A79B46DB422Q27644515-59B06CFC-54C2-40EB-BBAD-D5D13824979BQ27654848-A0909F09-F0F5-460B-B185-A6BA64E4359CQ27678062-53B85A33-3438-42EA-8379-977F2A36C37DQ27684529-D095AFEB-F74D-4EA4-AA0F-187C464D39AAQ30248405-AE8B6532-5BC2-4157-AD9D-23C800BEB427Q30362489-F90D6F5B-B0F6-4186-9F2C-0CF8057D1FE9Q30596957-BC62EA36-44D6-4367-92E3-A7387C839C4CQ33592852-6BECF6DB-4521-46D2-97E3-ACA944F1BD53Q33957908-3313FDCE-BFB4-434B-96ED-EBE8E4AFCC95Q34017550-E6DF196A-FF12-4541-8EFF-604145631B84Q34273397-CC091E69-DB00-4733-9A03-1F5CD72CCD35Q34312037-ECB6F781-184A-4504-A053-28E87194A3A9Q34368932-D3226E52-A3F6-480B-96FC-8247FED28FEFQ34399656-A333F3E3-7416-47F5-B0FB-F135F436DAD0Q34555891-BD6EB935-9CB8-4751-ADE4-1206F7E1F405Q34874985-6FD8D8F3-EC4C-43F4-A36A-705FA9AF48BFQ35000080-470B2A7E-861A-4074-AFC3-346C4DC98967Q35109028-C0CEDD13-9D03-4ACB-A72C-E8307EF55920Q35566508-F57878A8-3823-4425-80BF-A78603F5868CQ35641234-7F85D7E8-66AB-40B6-B521-F930ECD861C3Q35765737-3D983A8F-5066-48A0-B516-BF3E5B2515A4Q35902684-D50327DD-B964-41A6-8E1A-59025B78A4AAQ35913921-788E558F-7628-4F86-93D0-9DE86147D1CCQ35926734-7BFECD53-0503-4756-9A5A-084891EB1B5CQ35929985-6DC0D511-C109-4176-B719-6297D330AFEDQ35985519-D82E8E5E-464F-4BB1-AC05-65C3448E67FCQ36009232-4E49725E-FDBA-46A7-B88E-037790646F61Q36057328-0B04D05C-BB1C-4DF1-8403-E71E1E902725Q36079024-4A9D6EE9-54FD-4BE3-9908-170BBE65C93FQ36080800-D7ECFE1D-7AF4-42B7-B773-A47F735526A5Q36086229-277C1381-EC92-40DF-ACE1-6FB9BA0CE125Q36102994-66E41A31-C11A-4929-8236-B646CEEC8BBDQ36131738-6CF40F02-AA3E-4D39-99C4-C5787BA8B5FEQ36222292-484F96F4-1B06-42B7-95FB-151D028E855EQ36269097-4FFFBAF0-6FCC-4BCE-A2DE-7EB697F24E68Q36300767-E2A6EC27-DA68-42A6-97D2-3195EEF52659Q36433894-F3DAD4FC-0DDD-43E7-B416-D02D49425BA4
P2860
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
The Antibody Response against HIV-1
@ast
The Antibody Response against HIV-1
@en
The Antibody Response against HIV-1
@nl
type
label
The Antibody Response against HIV-1
@ast
The Antibody Response against HIV-1
@en
The Antibody Response against HIV-1
@nl
prefLabel
The Antibody Response against HIV-1
@ast
The Antibody Response against HIV-1
@en
The Antibody Response against HIV-1
@nl
P2860
P3181
P1476
The Antibody Response against HIV-1
@en
P2093
J. Overbaugh
P2860
P304
P3181
P356
10.1101/CSHPERSPECT.A007039
P407
P577
2012-01-01T00:00:00Z